FDA.reportPublic FDA data

POTASSIUM HYDROXIDE

Substance profile for UNII WZH3C48M4T, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for POTASSIUM HYDROXIDE
Structure render from PubChem CID 14797

Substance Identity#

UNII
WZH3C48M4T
Preferred term
POTASSIUM HYDROXIDE
Registry number
1310-58-3
EC number
215-181-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
K.HO
Chemical structure for POTASSIUM HYDROXIDE
Structure render from PubChem CID 14797

Chemical And Database Identifiers#

InChIKey
KWYUFKZDYYNOTN-UHFFFAOYSA-M
SMILES
[OH-].[K+]
RxCUI
34311
PubChem
14797
NCIt
C28204
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound14797pubchem.ncbi.nlm.nih.gov/compound/14797
PubChem InChIKey SearchKWYUFKZDYYNOTN-UHFFFAOYSA-Mpubchem.ncbi.nlm.nih.gov/#query=KWYUFKZDYYNOTN-UHFFFAOYSA-M
RxNorm34311mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=34311
NCI ThesaurusC28204ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28204
FDA Substance Registration SystemWZH3C48M4Tprecision.fda.gov/uniisearch/srs/unii/WZH3C48M4T
European Community number215-181-3commonchemistry.cas.org/results?q=215-181-3

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
LANSOPRAZOLE7
Cefadroxil Capsules USP 500 mg2
104fea5c-cb2a-16c3-e054-00144ff88e882
TEMAZEPAM1
Drug Facts5
Drug Facts3
GABAPENTIN2
These highlights do not include all the information needed to use esomeprazole magnesium safely and effectively. See full prescribing information for esomeprazole magnesium. Esomeprazole magnesium delayed-release capsules USP, for oral use Initial U.S. Approval: 1989 (omeprazole)6
These highlights do not include all the information needed to use duloxetine delayed-release capsules, USP safely and effectively. See full prescribing information for duloxetine delayed-release capsules, USP. DULOXETINE delayed-release capsules USP, for oral use. Initial U.S. Approval: 20047
Indomethacin Capsules USP, 25 mg and 50 mg5
3d8a20f7-0c4c-4c89-bddf-200194612b7a3
Ecosom Shampoo4
These highlights do not include all the information needed to use tacrolimus capsules safely and effectively. See full prescribing information for tacrolimus capsules. TACROLIMUS Capsules, USP for oral use Initial U.S. Approval: 19946
Kmart Corporation Miconazole Treatment Drug Facts3
These highlights do not include all the information needed to use ziprasidone safely and effectively. See full prescribing information for ziprasidone. ZIPRASIDONE hydrochloride capsules for oral use Initial U.S. Approval: 20013
Omeprazole DR2
Indomethacin Extended – Release Capsules, USP 75 mg5
Ecosom Tonic2
Drug Facts2
c635af0d-b005-4bce-8c43-24d0508c28ad5
NARS™ PRO-PRIME™ LIGHT OPTIMIZING PRIMER3
These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19894
Clearasil ® Daily Clear ® Hydra-Blast Oil-Free Face Wash2
These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19892
These highlights do not include all the information needed to use fluoxetine capsules safely and effectively. See full prescribing information for fluoxetine capsules. FLUOXETINE capsules, USP for oral use Initial U.S. Approval: 19873
Drug Facts1
Face Factor2
These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP . OMEPRAZOLE Delayed-Release Capsules, USP , for oral use INITIAL U.S. APPROVAL: 198915
Laura mercier flawless skin repair Day Creme Broad Spectrum SPF 153
Nantong Health & Beyond Green Soap2
VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES USP 7384 7385 7386 Rx only7
Maximum Strength Stomach Relief Liquid1
Drug Facts1
cd372f24-7f6c-46d0-86f3-ba8cfbebdff52
Dynarex Green3
CEPHALEXIN CAPSULES USP2
Well at Walgreens Oil-Free Daily Face Wash BONUS1
These highlights do not include all the information needed to use duloxetine delayed-release capsules USP safely and effectively. See full prescribing information for duloxetine delayed-release capsules USP. DULOXETINE delayed-release capsules USP for oral use Initial U.S. Approval: 20042
These highlights do not include all the information needed to use fluoxetine capsules, USP safely and effectively. See full prescribing information for fluoxetine capsules, USP. FLUOXETINE Capsules, USP for Oral Use Initial U.S. Approval: 19874
These highlights do not include all the information needed to use amlodipine besylate and benazepril hydrochloride capsules safely and effectively. See full prescribing information for amlodipine besylate and benazepril hydrochloride capsules. AMLODIPINE besylate and BENAZEPRIL hydrochloride capsules for oral use Initial U.S. Approval: 19951000
f1f051d8-b8d8-4afd-84d8-82a59d9fa4fb1
8d28ec4c-429b-4a2d-8ed5-f572db6c330c5
These highlights do not include all the information needed to use Duloxetine Delayed-release Capsules safely and effectively. See full prescribing information for Duloxetine Delayed-release Capsules. DULOXETINE delayed-release capsules USP for oral use. Initial U.S. Approval: 20042
These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19892
61f1d07a-f5e9-45b5-8806-b31a441bc5924
CEPHALEXIN CAPSULES, USP8
These highlights do not include all the information needed to use fluoxetine capsules, USP safely and effectively. See full prescribing information for fluoxetine capsules, USP. FLUOXETINE Capsules, USP for Oral Use Initial U.S. Approval: 198715
Quick Relief Diaper Rash Cream1
Miconazole 32
Drug Facts2
Lithium Carbonate Capsules USP1
GABAPENTIN CAPSULES, USP Rx only5
Yes To Carrots Daily Facial Moisturizer SPF 152
These highlights do not include all the information needed to use LYRICA safely and effectively. See full prescribing information for LYRICA. LYRICA (pregabalin) Capsules, CV LYRICA (pregabalin) Oral Solution, CV Initial U.S. Approval: 20044
These highlights do not include all the information needed to use Omeprazole safely and effectively. See full prescribing information for Omeprazole. Omeprazole (Omeprazole) CAPSULE for ORAL use. Initial U.S. Approval: 20133
Gabapentin Capsules, USP 100 mg, 300 mg and 400 mg2
8e36c36f-aa9e-4ae2-8dea-53d167e81a7f6
No7 Lift and Luminate Foundation Sunscreen Broad Spectrum SPF15 Toffee2
No7 Lift and Luminate Foundation Sunscreen Broad Spectrum SPF15 Hazelnut2
Clearasil ® Daily Clear ® Hydra-Blast Oil-Free Face Wash Sensitive1
These highlights do not include all the information needed to use ziprasidone hydrochloride capsules safely and effectively. See full prescribing information for ziprasidone hydrochloride capsules. Ziprasidone Hydrochloride Capsules Initial U.S. Approval: 20014
These highlights do not include all the information needed to use ziprasidone safely and effectively. See full prescribing information for ziprasidone. Ziprasidone Hydrochloride Capsules for Oral use Initial U.S. Approval: 20013
2226151
These highlights do not include all the information needed to use LYRICA safely and effectively. See full prescribing information for LYRICA. LYRICA (pregabalin) Capsules, CV LYRICA (pregabalin) Oral Solution, CV Initial U.S. Approval: 20042
Drug Facts2
CEPHALEXIN CAPSULES USP2
1b5d1614-4a4c-41d9-b9c1-733592695f143
Monistat ® 1 Combination Pack2
Monistat 7 Combination Pack Triple Action2
VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES 7384 7385 7386 Rx only6
SHISEIDO BENEFIANCE WRINKLERESIST24 DAY2
c9457679-ce84-40f1-8897-4db1e7a7de7c3
ddaa5c2d-fefa-4da3-987c-a363e85a440d2
No7 Protect and Perfect Intense Day Sunscreen Broad Spectrum SPF 15 - Skincare System2
Clearasil ® Daily Clear ® Vanishing Acne Treatment Cream2
Clearasil ® Daily Clear ® Tinted Acne Treatment Cream2
No7 Beautifully Matte Foundation Mocha2
No7 L and L Foundation Cool Vanilla3
No7 L and L Foundation Deeply Beige3
No7 L and L Foundation Cool Beige2
No7 L and L Foundation Cool Ivory2
No7 L and L Foundation Ebony2
No7 L and L Foundation Mocha2
No7 L and L Foundation Wheat2
01ad8667-972c-4281-97ad-b087c7e58ab62
f279f873-26c1-48eb-bf86-6d0f995b3be81
eeea080a-9655-44c8-9414-9ff9e013aa2b1
Udder Essence BETTER BALM Medicated1
CEPHALEXIN CAPSULES USP2
Temazepam Capsules, USP Novel Laboratories, Inc. Rx only4
MONISTAT® 3 COMBINATION PACK2
Carton and jar labelling4
Vaseline Petroleum Jelly Cream Deep Moisture PDP and drug facts2
f262196e-c78d-4e2f-9662-d49d87d3ce471
Carton and jar labelling2
LIGHT THE WAY5
DRUG FACTS1
2ed81194-be24-45a0-8dde-fbc6ad3d7abe4
CLINDAMYCIN HYDROCHLORIDE CAPSULES, USP Rx only2
These highlights do not include all the information needed to use Amlodipine Besylate and Benazepril Hydrochloride Capsules safely and effectively. See full prescribing information for Amlodipine Besylate and Benazepril Hydrochloride Capsules. Amlodipine Besylate and Benazepril Hydrochloride Capsules Initial U.S. Approval: 19955
Isradipine Capsules, USP3
These highlights do not include all the information needed to use LYRICA safely and effectively. See full prescribing information for LYRICA. LYRICA (pregabalin) Capsules, CV LYRICA (pregabalin) Oral Solution, CV Initial U.S. Approval: 20045
FULL PRESCRIBING INFORMATION These highlights do not include all the information needed to use OMEPRAZOLE DELAYED-RELEASE safely and effectively. See full prescribing information for OMEPRAZOLE DELAYED-RELEASE. OMEPRAZOLE DELAYED-RELEASE (omeprazole) capsule, delayed release for oral use Initial U.S. Approval: 19893
Amoxicillin Capsules, Tablets and Powder for Oral Suspension, USP6
CEPHALEXIN CAPSULES USP3
Cefadroxil Capsules USP 500 mg2
CLINDAMYCIN HYDROCHLORIDE CAPSULES, USP Rx only2
Indomethacin Capsules USP, 25 mg and 50 mg3
These highlights do not include all the information needed to use lansoprazole delayed-release capsules USP safely and effectively. See full prescribing information for lansoprazole delayed-release capsules USP. LANSOPRAZOLE delayed-release capsules USP for oral use Initial U.S. Approval: 19954
Lithium Carbonate Capsules USP Rx Only6
These highlights do not include all the information needed to use LYRICA safely and effectively. See full prescribing information for LYRICA. LYRICA (pregabalin) Capsules, CV LYRICA (pregabalin) Oral Solution, CV Initial U.S. Approval: 20043362
Indomethacin Extended – Release Capsules, USP 75 mg3231
These highlights do not include all the information needed to use LYRICA safely and effectively. See full prescribing information for LYRICA. LYRICA (pregabalin) Capsules, CV LYRICA (pregabalin) Oral Solution, CV Initial U.S. Approval: 20044
These highlights do not include all the information needed to use tamsulosin hydrochloride capsules safely and effectively. See full prescribing information for tamsulosin hydrochloride capsules. Tamsulosin Hydrochloride Capsules, 0.4 mg Initial U.S. Approval: 19973
ba5c415e-2a44-4b49-b85a-55984e3131b83
Strazepam17
These highlights do not include all the information needed to use tamsulosin hydrochloride safely and effectively. See full prescribing information for tamsulosin hydrochloride. Tamsulosin Hydrochloride Capsules USP*, 0.4 mg Initial U.S. Approval: 19971
Cephalexin Capsule2
CEPHALEXIN CAPSULES USP2
Indomethacin Capsules USP, 25 mg2

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII WZH3C48M4T page 1 of 1 · 13 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
POTASSIUM HYDROXIDEWZH3C48M4T1310583SOLUTIONINTRAVASCULARNA
POTASSIUM HYDROXIDEWZH3C48M4T1310583INJECTIONINTRAVENOUSADJ PH
POTASSIUM HYDROXIDEWZH3C48M4T1310583CAPSULEORAL172 mg
POTASSIUM HYDROXIDEWZH3C48M4T1310583CAPSULE, DELAYED RELEASEORAL5 mg
POTASSIUM HYDROXIDEWZH3C48M4T1310583CAPSULE, EXTENDED RELEASEORAL0.07 mg
POTASSIUM HYDROXIDEWZH3C48M4T1310583CAPSULE, LIQUID FILLEDORAL154 mg
POTASSIUM HYDROXIDEWZH3C48M4T1310583PASTILLEORALADJ PH
POTASSIUM HYDROXIDEWZH3C48M4T1310583SOLUTIONORALADJ PH
POTASSIUM HYDROXIDEWZH3C48M4T1310583AEROSOL, FOAMTOPICALADJ PH
POTASSIUM HYDROXIDEWZH3C48M4T1310583CREAMTOPICAL0.5 %w/w
POTASSIUM HYDROXIDEWZH3C48M4T1310583GELTOPICAL3 mg
POTASSIUM HYDROXIDEWZH3C48M4T1310583SOLUTIONTOPICAL14.02 %w/w
POTASSIUM HYDROXIDEWZH3C48M4T1310583CREAMVAGINAL3 mg